Product NDC: | 43353-474 |
Proprietary Name: | PRAVASTATIN SODIUM |
Non Proprietary Name: | PRAVASTATIN SODIUM |
Active Ingredient(s): | 40 mg/1 & nbsp; PRAVASTATIN SODIUM |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 43353-474 |
Labeler Name: | Aphena Pharma Solutions - Tennessee, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076341 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110718 |
Package NDC: | 43353-474-45 |
Package Description: | 45 TABLET in 1 BOTTLE, PLASTIC (43353-474-45) |
NDC Code | 43353-474-45 |
Proprietary Name | PRAVASTATIN SODIUM |
Package Description | 45 TABLET in 1 BOTTLE, PLASTIC (43353-474-45) |
Product NDC | 43353-474 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | PRAVASTATIN SODIUM |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110718 |
Marketing Category Name | ANDA |
Labeler Name | Aphena Pharma Solutions - Tennessee, Inc. |
Substance Name | PRAVASTATIN SODIUM |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |